Search Results - "Karakousis, G. C."

Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study by Ecker, B.L, McMillan, M.T, Datta, J, Dempsey, D.T, Karakousis, G.C, Fraker, D.L, Drebin, J.A, Mamtani, R, Giantonio, B.J, Roses, R.E

“…Abstract Background Lymph node (LN) metastasis in patients with duodenal adenocarcinoma is associated with poor prognosis; however, the optimal extent of LN…”
Get full text

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma by Sharon, C.E., Tortorello, G.N., Ma, K.L., Huang, A.C., Xu, X., Giles, L.R., McGettigan, S., Kreider, K., Schuchter, L.M., Mathew, A.J., Amaravadi, R.K., Gimotty, P.A., Miura, J.T., Karakousis, G.C., Mitchell, T.C.

“…While neoadjuvant immunotherapy for melanoma has shown promising results, the data have been limited by a relatively short follow-up time, with most studies…”
Get full text

Sentinel lymph node positivity and overall survival in immunosuppressed patients with Merkel cell carcinoma: a national cohort study by Song, Y., Zheng, C., Shannon, A.B., Fraker, D.L., Miura, J.T., Karakousis, G.C.

Get full text

Preoperative radiotherapy in the management of retroperitoneal liposarcoma by Ecker, B. L., Peters, M. G., McMillan, M. T., Sinnamon, A. J., Zhang, P. J., Fraker, D. L., Levin, W. P., Roses, R. E., Karakousis, G. C.

“…Background Histological subtype influences both prognosis and patterns of treatment failure in retroperitoneal sarcoma. Previous studies on the efficacy of…”
Get full text

The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases: A multicenter cohort study by Olofsson Bagge, Roger, Holmberg, Carl Jacob, Hieken, Tina J., Zager, Jonathan S., Long, Georgina V., Van Akkooi, Alexander Christopher Jonathan, Karakousis, Giorgos C, Pallan, Lalit, Vetto, John T., Gyorki, David E., Ascierto, Paolo Antonio, Dummer, Reinhard, Hui, Jane Yuet Ching, Schachter, Jacob, Helgadottir, Hildur, Kroon, Hidde, Rothermel, Luke Daniel, Carlino, Matteo S., Broman, Kristy Kummerow, Ny, Lars

“…9569 Background: Guidelines addressing melanoma in-transit metastasis (ITM) recommend immune checkpoint inhibitors (ICI) as a first-line treatment option,…”
Get full text

Mitotic rate as a predictor for sentinel lymph node positivity in patients with thin melanomas by Kesmodel, S. B., Karakousis, G. C., Terhune, K. P., Canter, R. J., Wahl, P., Gimotty, P., Guerry, D., Fraker, D. L., Czerniecki, B. J., Spitz, F. R.

Get full text

Tertiary Hyperparathyroidism in Kidney Transplant Recipients: Characteristics of Patients Selected for Different Treatment Strategies by YANG, Rachel L, FREEMAN, Kate, REINKE, Caroline E, FRAKER, Douglas L, KARAKOUSIS, Giorgos C, KELZ, Rachel R, DOYLE, Alden M

“…Several treatment options exist for kidney transplant patients with tertiary hyperparathyroidism. However, the decision to endorse observation (OBS), medical…”
Get full text

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 + T cells by Wang, Kevin, Coutifaris, Paulina, Brocks, David, Wang, Guanning, Azar, Tarek, Solis, Sabrina, Nandi, Ajeya, Anderson, Shaneaka, Han, Nicholas, Manne, Sasikanth, Kiner, Evgeny, Sachar, Chirag, Lucas, Minke, George, Sangeeth, Yan, Patrick K, Kier, Melanie W, Laughlin, Amy I, Kothari, Shawn, Giles, Josephine, Mathew, Divij, Ghinnagow, Reem, Alanio, Cecile, Flowers, Ahron, Xu, Wei, Tenney, Daniel J, Xu, Xiaowei, Amaravadi, Ravi K, Karakousis, Giorgos C, Schuchter, Lynn M, Buggert, Marcus, Oldridge, Derek, Minn, Andy J, Blank, Christian, Weber, Jeffrey S, Mitchell, Tara C, Farwell, Michael D, Herati, Ramin S, Huang, Alexander C

“…Combination checkpoint blockade with anti-PD-1 and anti-CTLA-4 antibodies has shown promising efficacy in melanoma. However, the underlying mechanism in humans…”
Get more information

Clinical behavior of retroperitoneal sarcomas that express HIF-1α, PHD2 and/or VEGF by Han, D., Karakousis, G. C., Huang, J., Bartlett, E., Pasha, T. L., Lee, F. S., Zhang, P. J., Fraker, D. L.

“…Abstract only…”
Get full text

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas by Kesmodel, Susan B, Karakousis, Giorgos C, Botbyl, Jeffrey D, Canter, Robert J, Lewis, Robert T, Wahl, Peter M, Terhune, Kyla P, Alavi, Abass, Elder, David E, Ming, Michael E, Guerry, DuPont, Gimotty, Phyllis A, Fraker, Douglas L, Czerniecki, Brian J, Spitz, Francis R

“…Lymphatic mapping and sentinel lymphadenectomy (LM/SL) provide important prognostic information for patients with early-stage melanoma. Although the use of…”
Get full text

Predictors of regional nodal disease in patients with thin melanomas by Karakousis, Giorgos C, Gimotty, Phyllis A, Botbyl, Jeffrey D, Kesmodel, Susan B, Elder, David E, Elenitsas, Rosalie, Ming, Michael E, Guerry, DuPont, Fraker, Douglas L, Czerniecki, Brian J, Spitz, Francis R

“…Most melanoma patients present with thin (<or=1.0 mm) lesions. Indications for sentinel lymph node (SLN) biopsy are not well defined for this group…”
Get full text

Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome by Szeto, Wilson Y., Kreisel, Daniel, Karakousis, Giorgos C., Pochettino, Alberto, Sterman, Daniel H., Kotloff, Robert M., Arcasoy, Selim M., Zisman, David A., Blumenthal, Nancy P., Gallop, Robert J., Kaiser, Larry R., Bavaria, Joseph E., Rosengard, Bruce R.

“…Objective: The use of cardiopulmonary bypass in lung transplantation remains controversial. Previous studies have concluded that cardiopulmonary bypass is…”
Get full text